아이케어 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 구매 형태별, 유통 채널별, 지역별, 부문별 예측(2024-2030년)

Eye Care Market Growth & Trends:

The global eye care market size is expected to reach USD 110.33 billion by 2030, growing at a CAGR of 6.72% over the forecast period, according to a new report by Grand View Research, Inc. The market is experiencing significant growth, likely driven by the rising prevalence of eye illnesses, aging population, and technological advancements. Government initiatives to enhance healthcare infrastructure and broaden access to vision care services have been instrumental in this market expansion.

For instance, the Vision Catalyst Fund (VCF) launched a new phase offering USD 1.06 million in grants for vision programs. The fund targets programs that effectively scale ocular health services through market shaping for glasses or by developing public health services to combat ocular disease. It has provided grants from USD 16,000 to USD 213,000 to help expand vision care access across low- and middle-income countries. Funding for these grants is obtained from an Eye Health Accelerator Bond, a collaborative effort between the VCF and P1 Capital, enabling investors to allocate a portion of their returns toward vision wellbeing programs. This innovative approach demonstrates a commitment to utilizing financial mechanisms to address the escalating demand for vision care services globally.

In addition, the donations for glasses and lenses are sought for expressions of interest, aiming to enhance access to lenses through catalytic, multiyear programs. This collective endeavor underscores the pivotal role of public-private partnerships and innovative financing models in advancing vision care access & outcomes worldwide.

The Eye Health Investment Study, published in November 2023, highlighted a compelling Return on Investment (ROI) ratio of 36:1, indicating that every dollar spent on cataract or refractive error correction results in USD 36 worth of benefits for individuals and society. This ROI ratio places ocular health investments at par with, if not exceeding, other recognized "best buys" in global health. Despite the evident economic advantages, ocular health continues to receive significantly lower funding than other health sectors, such as nutrition & noncommunicable diseases. The WHO estimates that nearly 2.2 billion people worldwide suffer from vision impairment, highlighting the urgency for increased investment and attention to ocular health. The study scheduled for publication in the December 2023 issue of the Bulletin of the World Health Organization underscores a critical funding gap of USD 14.3 billion, emphasizing the need for greater prioritization of ocular health on the global agenda.

Initiatives undertaken by players are expanding the market and enhancing the accessibility & quality of vision care products & services. Through continuous innovation and adaptation, these companies are shaping the future of the eye care industry, addressing key challenges, and seizing opportunities for growth in a rapidly evolving market landscape. For instance, in April 2024, Viatris launched RYZUMVI, the first FDA-approved eye drop to reverse pharmacologically induced mydriasis, in the U.S. It is designed to counteract pupil dilation caused by certain medications, aiding eye exams. The product supports standard dilation practice in eye care, which is crucial for diagnosing ocular and systemic diseases. This initiative addresses a key challenge in eye care, potentially increasing the number of annual comprehensive eye exams, leading to earlier diagnoses and improved patient outcomes.

Eye Care Market Report Highlights:

• Based on product, the contact lens segment accounted for the largest revenue share of 36.42% in 2023 due to their effectiveness in addressing complex retinal issues and providing patients with clear vision at different distances.
• Based on mode of purchase, the prescribed products segment accounted for the largest revenue share in 2023.
• Based on distribution channel, the hospitals & clinics segment accounted for the largest revenue share of 35.92% in 2023.With access to specialized equipment & expertise, hospitals & clinics serve as trusted hubs for addressing complex eye conditions and providing continuity of care.
• In 2023, North America dominated the global industry as this region is a hub for technological innovation, with continuous advancements in diagnostic and treatment options.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Mode of Purchase
  • 1.2.3. Distribution Channel
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Mode of purchase outlook
  • 2.2.3. Distribution Channel outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Eye Care Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising awareness towards the importance of eye health and safety
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Rising geriatric population
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Technological limitations
• 3.3. Eye Care Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Eye Care Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Eye Care Market: Product Movement Analysis
• 4.3. Eye Care Market by Product Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Contact Lens
  • 4.5.1. Contact Lens Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Intraocular Lens
  • 4.6.1. Intraocular Lens Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Ocular Health Products
  • 4.7.1. Ocular Health Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Others
  • 4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Eye Care Market: Mode of Purchase Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Eye Care Market: Mode of Purchase Movement Analysis
• 5.3. Eye Care Market by Mode of Purchase Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Over-The-Counter (OTC) Products
  • 5.5.1. Over-The-Counter (OTC) Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Prescribed (Rx) Products
  • 5.6.1. Prescribed (Rx) Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Eye Care Market: Distribution Channel Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Eye Care Market: Distribution Channel Movement Analysis
• 6.3. Eye Care Market by Distribution Channel Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Hospitals & Clinics
  • 6.5.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Retail Stores
  • 6.6.1. Retail Stores Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Online Stores
  • 6.7.1. Online Stores Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Others
  • 6.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Eye Care Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Eye Care Market movement analysis
• 7.3. Eye Care Market: Regional Estimates & Trend Analysis by Technology & End Use
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. North America
  • 7.5.1. North America Eye Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. U.S. Eye Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Canada Eye Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. Mexico Eye Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Europe
  • 7.5.6. Europe Eye Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. UK
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Reimbursement scenario
    • 7.5.7.5. UK Eye Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Germany
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Competitive Scenario
    • 7.5.8.3. Regulatory Framework
    • 7.5.8.4. Reimbursement scenario
    • 7.5.8.5. Germany Eye Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. France
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Competitive Scenario
    • 7.5.9.3. Regulatory Framework
    • 7.5.9.4. Reimbursement scenario
    • 7.5.9.5. France Eye Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.10. Italy
    • 7.5.10.1. Key Country Dynamics
    • 7.5.10.2. Competitive Scenario
    • 7.5.10.3. Regulatory Framework
    • 7.5.10.4. Reimbursement scenario
    • 7.5.10.5. Italy Eye Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.11. Spain
    • 7.5.11.1. Key Country Dynamics
    • 7.5.11.2. Competitive Scenario
    • 7.5.11.3. Regulatory Framework
    • 7.5.11.4. Reimbursement scenario
    • 7.5.11.5. Spain Eye Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.12. Denmark
    • 7.5.12.1. Key Country Dynamics
    • 7.5.12.2. Competitive Scenario
    • 7.5.12.3. Regulatory Framework
    • 7.5.12.4. Reimbursement scenario
    • 7.5.12.5. Denmark Eye Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.13. Sweden
    • 7.5.13.1. Key Country Dynamics
    • 7.5.13.2. Competitive Scenario
    • 7.5.13.3. Regulatory Framework
    • 7.5.13.4. Reimbursement scenario
    • 7.5.13.5. Sweden Eye Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.14. Norway
    • 7.5.14.1. Key Country Dynamics
    • 7.5.14.2. Competitive Scenario
    • 7.5.14.3. Regulatory Framework
    • 7.5.14.4. Reimbursement scenario
    • 7.5.14.5. Norway Eye Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Eye Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Japan Eye Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. China Eye Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. India Eye Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. South Korea Eye Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Australia
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Australia Eye Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Thailand Eye Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Eye Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Brazil Eye Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. Argentina Eye Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Middle East & Africa
  • 7.8.1. Middle East & Africa Eye Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. South Africa Eye Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. Saudi Arabia Eye Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory Framework
    • 7.8.4.4. Reimbursement scenario
    • 7.8.4.5. UAE Eye Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory Framework
    • 7.8.5.4. Reimbursement scenario
    • 7.8.5.5. Kuwait Eye Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Alcon, Inc.
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Johnson and Johnson Eye Care, Inc.
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Bausch & Lomb Incorporated
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Carl Zeiss Meditec AG (ZEISS International)
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Essilor International
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. CooperVision
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. HOYA CORPORATION
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Rayner
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. STAAR SURGICAL
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Novartis AG
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives